.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Hydrochlorothiazide; moexipril hydrochloride - Generic Drug Details

« Back to Dashboard
Hydrochlorothiazide; moexipril hydrochloride is the generic ingredient in three branded drugs marketed by Glenmark Pharms, Ucb Inc, Heritage Pharms Inc, Teva, and Paddock Llc, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-one drug master file entries for hydrochlorothiazide; moexipril hydrochloride. Three suppliers are listed for this compound.

Summary for Generic Name: hydrochlorothiazide; moexipril hydrochloride

Tradenames:3
Patents:0
Applicants:5
NDAs:5
Drug Master File Entries: see list31
Suppliers / Packaging: see list3
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: hydrochlorothiazide; moexipril hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Paddock Llc
MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; moexipril hydrochloride
TABLET;ORAL090096-003Sep 25, 2008DISCNNo► subscribe► subscribe
Heritage Pharms Inc
MOEXIPRIL HYDROCHLORIDE AND HYDROCHOLROTHIAZIDE
hydrochlorothiazide; moexipril hydrochloride
TABLET;ORAL202150-002Mar 7, 2014RXNo► subscribe► subscribe
Heritage Pharms Inc
MOEXIPRIL HYDROCHLORIDE AND HYDROCHOLROTHIAZIDE
hydrochlorothiazide; moexipril hydrochloride
TABLET;ORAL202150-001Mar 7, 2014RXNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: hydrochlorothiazide; moexipril hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ucb Inc
UNIRETIC
hydrochlorothiazide; moexipril hydrochloride
TABLET;ORAL020729-001Jun 27, 19974,344,949► subscribe
Ucb Inc
UNIRETIC
hydrochlorothiazide; moexipril hydrochloride
TABLET;ORAL020729-003Feb 14, 20024,743,450► subscribe
Ucb Inc
UNIRETIC
hydrochlorothiazide; moexipril hydrochloride
TABLET;ORAL020729-002Jun 27, 19974,743,450► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc